Ben Rogers

Learn more about the people at Monash Infectious Diseases.

MBBS (Hons) (Monash) FRACP

Infectious Diseases Physician
Victorian Coordinating Centre, ASID Clinical Research Network

2013-2014 Senior Lecturer, School of Medicine, U Queensland

Professional Roles
2010-2014    Research Scholar, Infection & Immunity Theme, UQCCR
2012-2013    Member, Multi-Resistant Gram-negative Bacilli task force, ACSQHC
2012-2013    Member, ESBL Steering Committee & MERINO Study, ASID CRN

2013            Best Clinical Science Oral, Annual Symposium, Royal Brisbane Hospital
2010-13       Australian Postgraduate Award, U Queensland
2012            Post-Doctoral Fellow ICAAC Travel Grant, ASM
2012            Shimadzu Outstanding Young Investigator Award, UQCCR
2011            ICAAC Infectious Diseases Fellows Grant, ASM
2011            ASID Council Scholarship, ASID
2010            Comprehensive Course in Epidemiology Scholarship, ESCMID-SHEA-ASID
2008            Best Clinical Case Presentation Prize, ASHM Annual Scientific Meeting

Journal Articles

Mycobacterium tuberculosis: Active disease and latent infection in a renal transplant cohort.
Rafiei N, Williams J, Mulley WR, Trauer JM, Jenkin GA, Rogers BA.
Nephrology (Carlton). 2018 Apr 16. doi: 10.1111/nep.13386. [Epub ahead of print]
PMID: 29660203

Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27.
Harris PNA, Ben Zakour NL, Roberts LW, Wailan AM, Zowawi HM, Tambyah PA, Lye DC, Jureen R, Lee TH, Yin M, Izharuddin E, Looke D, Runnegar N, Rogers B, Bhally H, Crowe A, Schembri MA, Beatson SA, Paterson DL; MERINO Trial investigators.
J Antimicrob Chemother. 2017 Dec 14. doi: 10.1093/jac/dkx466. [Epub ahead of print]
PMID: 29253152

Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition.
Harris PN, McNamara JF, Lye DC, Davis JS, Bernard L, Cheng AC, Doi Y, Fowler VG Jr, Kaye KS, Leibovici L, Lipman J, Llewelyn MJ, Munoz-Price S, Paul M, Peleg AY, Rodríguez-Baño J, Rogers BA, Seifert H, Thamlikitkul V, Thwaites G, Tong SY, Turnidge J, Utili R, Webb SA, Paterson DL.
Clin Microbiol Infect. 2016 Nov 1. pii: S1198-743X(16)30512-2. doi: 10.1016/j.cmi.2016.10.023. [Epub ahead of print] Review.
PMID: 27810466

Tai A, Stuart RL, Sidjabat H, Lemoh C, Rogers BA, Graham M, Paterson DL, Korman TM.
Med J Aust 2015 Mar 16;202(5):270-1.
Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand.
Rogers BA, Ingram PR, Runnegar N, Pitman MC, Freeman JT, Athan E, Havers S, Sidjabat HE, Gunning E, De Almeida M, Styles K, Paterson DL; ASID CRN.
Int J Antimicrob Agents. 2015 Jan 13. pii: S0924-8579(15)00004-7. doi: 10.1016/j.ijantimicag.2014.11.015. [Epub ahead of print]
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.
Harris P, Peleg AY, Iredell J, Ingram PR, Miyakis S, Stewardson AJ, Rogers BA, McBryde ES, Roberts JA, Lipman J, Athan E, Paul SK, Baker P, Harris-Brown T, Paterson DL.
Trials. 2015 Jan 27;16(1):24. [Epub ahead of print]
PMID: 25623485 [PubMed – as supplied by publisher]
Do Human Extraintestinal Escherichia coli Infections Resistant to Expanded-Spectrum Cephalosporins Originate From Food-Producing Animals? A Systematic Review.
Lazarus B, Paterson DL, Mollinger JL, Rogers BA.
Clin Infect Dis. 2014 Oct 9. pii: ciu785. [Epub ahead of print]
PMID: 25301206 [PubMed – as supplied by publisher]
Predictors of use of infection control precautions for multiresistant gram-negative bacilli in Australian hospitals: analysis of a national survey.
Rogers BA, Havers SM, Harris-Brown TM, Paterson DL.
Am J Infect Control. 2014 Sep;42(9):963-9. doi: 10.1016/j.ajic.2014.05.035.
PMID: 25179327 [PubMed – in process]
Global dissemination of a multidrug resistant Escherichia coli clone.
Petty NK, Ben Zakour NL, Stanton-Cook M, Skippington E, Totsika M, Forde BM, Phan MD, Gomes Moriel D, Peters KM, Davies M, Rogers BA, Dougan G, Rodriguez-Baño J, Pascual A, Pitout JD, Upton M, Paterson DL, Walsh TR, Schembri MA, Beatson SA.
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5694-9. doi: 10.1073/pnas.1322678111. Epub 2014 Mar 31.
PMID: 24706808 [PubMed – indexed for MEDLINE]Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries.
Rogers BA, Ingram PR, Runnegar N, Pitman MC, Freeman JT, Athan E, Havers SM, Sidjabat HE, Jones M, Gunning E, De Almeida M, Styles K, Paterson DL; Australasian Society for Infectious Diseases Clinical Research Network.
Antimicrob Agents Chemother. 2014 Apr;58(4):2126-34. doi: 10.1128/AAC.02052-13. Epub 2014 Jan 27.
PMID: 24468775 [PubMed – in process]

Co-selection may explain high rates of ciprofloxacin non-susceptible Escherichia coli from retail poultry reared without prior fluoroquinolone exposure.
Ingram PR, Rogers BA, Sidjabat HE, Gibson JS, Inglis TJ.
J Med Microbiol. 2013 Nov;62(Pt 11):1743-6. doi: 10.1099/jmm.0.062729-0.
PMID: 24136884 [PubMed – indexed for MEDLINE]

Rectal colonization with New Delhi metallo-β-lactamase-1-producing Escherichia coli prior to transrectal ultrasound (TRUS)-guided prostate biopsy.
Williamson DA, Freeman JT, Roberts SA, Heffernan H, Dyet K, Paterson DL, Rogers BA, Sidjabat HE, Masters J.
J Antimicrob Chemother. 2013 Dec;68(12):2957-9. doi: 10.1093/jac/dkt266. Epub 2013 Jul 3. No abstract available.
PMID: 23825384 [PubMed – in process]

Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli.
Williamson DA, Barrett LK, Rogers BA, Freeman JT, Hadway P, Paterson DL.
Clin Infect Dis. 2013 Jul;57(2):267-74. doi: 10.1093/cid/cit193. Epub 2013 Mar 26. Review.
PMID: 23532481 [PubMed – indexed for MEDLINE]

Who is leading this dance? Understanding the spread of Escherichia coli sequence type 131.
Rogers BA, Doi Y.
Infect Control Hosp Epidemiol. 2013 Apr;34(4):370-2. doi: 10.1086/669874. Epub 2013 Feb 13. No abstract available.
PMID: 23466909 [PubMed – indexed for MEDLINE]

Treatment options for New Delhi metallo-beta-lactamase-harboring enterobacteriaceae.
Rogers BA, Sidjabat HE, Silvey A, Anderson TL, Perera S, Li J, Paterson DL.
Microb Drug Resist. 2013 Apr;19(2):100-3. doi: 10.1089/mdr.2012.0063. Epub 2013 Jan 18.
PMID: 23330550 [PubMed – indexed for MEDLINE]

Vancomycin therapeutics and monitoring: a contemporary approach.
Avent ML, Vaska VL, Rogers BA, Cheng AC, van Hal SJ, Holmes NE, Howden BP, Paterson DL.
Intern Med J. 2013 Feb;43(2):110-9. doi: 10.1111/imj.12036. Review.
PMID: 23185970 [PubMed – indexed for MEDLINE]

An oral carbapenem, but only now intravenous penicillin: the paradox of Japanese antimicrobials.
Rogers BA, Hayashi Y.
Int J Infect Dis. 2012 Dec;16(12):e830-2. doi: 10.1016/j.ijid.2012.08.001. Epub 2012 Oct 5.
PMID: 23041363 [PubMed – indexed for MEDLINE]

Uropathogenic Escherichia coli mediated urinary tract infection.
Totsika M, Moriel DG, Idris A, Rogers BA, Wurpel DJ, Phan MD, Paterson DL, Schembri MA.
Curr Drug Targets. 2012 Oct;13(11):1386-99.
PMID: 22664092 [PubMed – indexed for MEDLINE]

Prolonged carriage of resistant E. coli by returned travellers: clonality, risk factors and bacterial characteristics.
Rogers BA, Kennedy KJ, Sidjabat HE, Jones M, Collignon P, Paterson DL.
Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2413-20. doi: 10.1007/s10096-012-1584-z. Epub 2012 Mar 7.
PMID: 22391758 [PubMed – indexed for MEDLINE]

Country-to-country transfer of patients and the risk of multi-resistant bacterial infection.
Rogers BA, Aminzadeh Z, Hayashi Y, Paterson DL.
Clin Infect Dis. 2011 Jul 1;53(1):49-56. doi: 10.1093/cid/cir273. Review.
PMID: 21653302 [PubMed – indexed for MEDLINE]

Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity.
Avent ML, Rogers BA, Cheng AC, Paterson DL.
Intern Med J. 2011 Jun;41(6):441-9. doi: 10.1111/j.1445-5994.2011.02452.x. Review.
PMID: 21309997 [PubMed – indexed for MEDLINE]

Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain.
Rogers BA, Sidjabat HE, Paterson DL.
J Antimicrob Chemother. 2011 Jan;66(1):1-14. doi: 10.1093/jac/dkq415. Epub 2010 Nov 16. Review.
PMID: 21081548 [PubMed – indexed for MEDLINE]

How soon is now? The urgent need for randomized, controlled trials evaluating treatment of multidrug-resistant bacterial infection.
Paterson DL, Rogers BA.
Clin Infect Dis. 2010 Dec 1;51(11):1245-7. doi: 10.1086/657243. Epub 2010 Oct 25. No abstract available.
PMID: 20973726 [PubMed – indexed for MEDLINE]

Disproportionate impact of pandemic (H1N1) 2009 influenza on Indigenous people in the Top End of Australia’s Northern Territory.
Flint SM, Davis JS, Su JY, Oliver-Landry EP, Rogers BA, Goldstein A, Thomas JH, Parameswaran U, Bigham C, Freeman K, Goldrick P, Tong SY.
Med J Aust. 2010 May 17;192(10):617-22.
PMID: 20477746 [PubMed – indexed for MEDLINE]

Imported West Nile virus encephalitis in an Israeli tourist.
Rogers BA, Hueston L, Ratnam I.
Med J Aust. 2009 Aug 17;191(4):232-4.
PMID: 19705988 [PubMed – indexed for MEDLINE]

Methicillin resistant Staphylococcus aureus endocarditis in an Australian tertiary hospital: 1991-2006.
Rogers BA, Drake AK, Spelman D.
Heart Lung Circ. 2009 Jun;18(3):208-13. doi: 10.1016/j.hlc.2008.10.016. Epub 2008 Dec 31.
PMID: 19119075 [PubMed – indexed for MEDLINE]